相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Resistin: Potential biomarker and therapeutic target in atherosclerosis
Li Zhou et al.
CLINICA CHIMICA ACTA (2021)
Peptide hormones and risk for future cardiovascular events among prediabetics: a 20-year follow-up in the OPERA study
Olli-Juhani Galla et al.
ANNALS OF MEDICINE (2020)
Nonalcoholic Steatohepatitis: A Review
Adam C. Sheka et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Medical liver biopsy: background, indications, procedure and histopathology
Alexander Boyd et al.
FRONTLINE GASTROENTEROLOGY (2020)
Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk
Manuel F. Landecho et al.
NUTRIENTS (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017Part 1: Definition, risk factors and assessment
Vincent Wai-Sun Wong et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Resistin levels in non-alcoholic fatty liver disease pathogenesis
Carmela Colica et al.
JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE (2018)
MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat
Giovanni Musso et al.
HUMAN MOLECULAR GENETICS (2017)
Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients
Rafael Bergesch D'Incao et al.
OBESITY SURGERY (2017)
Increased serum resistin level is associated with coronary heart disease
Jing-Zhan Zhang et al.
ONCOTARGET (2017)
The Correlation Between Serum Adipokines and Liver Cell Damage in Non-Alcoholic Fatty Liver Disease
Raika Jamali et al.
HEPATITIS MONTHLY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease: Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
A. Lonardo et al.
HEPATOLOGY (2016)
Adipokines in in nonalcoholic fatty liver disease
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease
Raika Jamali et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case-control study
Jin-Zhou Zhu et al.
ENDOCRINE (2016)
Circulating resistin protein and mRNA concentrations and clinical severity of coronary artery disease
Jelena Joksic et al.
BIOCHEMIA MEDICA (2015)
The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitis
Chuan Shen et al.
BMC GASTROENTEROLOGY (2014)
Hypoadiponectinaemia in nonalcoholic fatty liver disease obese women is associated with infrequent intake of dietary sucrose and fatty foods
G. C. B. Magalhaes et al.
JOURNAL OF HUMAN NUTRITION AND DIETETICS (2014)
Endocannabinoid Receptors Gene Expression in Morbidly Obese Women with Nonalcoholic Fatty Liver Disease
Teresa Auguet et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Impact of sterol regulatory element-binding factor-1c polymorphism on incidence of nonalcoholic fatty liver disease and on the severity of liver disease and of glucose and lipid dysmetabolism
Giovanni Musso et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2013)
Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease
Teresa Auguet et al.
CLINICAL BIOCHEMISTRY (2013)
Nonalcoholic steatohepatitis versus steatosis: Adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism
Giovanni Musso et al.
HEPATOLOGY (2012)
Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients
Edith Koehler et al.
LIVER INTERNATIONAL (2012)
Analysis of adipokine concentrations in paediatric non-alcoholic fatty liver disease
E. Fitzpatrick et al.
PEDIATRIC OBESITY (2012)
A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis
Zobair M. Younossi et al.
OBESITY SURGERY (2011)
Resistin is Associated with Breach of Tolerance and Anti-nuclear Antibodies in Patients with Hepatobiliary Inflammation
E. A. Bostrom et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2011)
Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis?
Cem Cengiz et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Patients with nonalcoholic fatty liver disease display increased serum resistin levels and decreased adiponectin levels
Ling-Ling Jiang et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2009)
Adipokine Serum Levels Are Related to Liver Histology in Severely Obese Patients Undergoing Bariatric Surgery
Marianna Argentou et al.
OBESITY SURGERY (2009)
Serum adipokine profile in Indian men with nonalcoholic steatohepatitis: Serum adiponectin is paradoxically decreased in lean vs. obese patients
Madhusudana Girija Sanal et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2009)
Plasma adiponectin levels in primary biliary cirrhosis: A novel perspective for link between hypercholesterolemia and protection against atherosclerosis
Annarosa Floreani et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
A Novel Diagnostic Biomarker Panel for Obesity-related Nonalcoholic Steatohepatitis (NASH)
Zobair M. Younossi et al.
OBESITY SURGERY (2008)
Serum adipokine levels in chronic liver diseases: Association of resistin levels with fibrosis severity
Emmanuel Tsochatzis et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2008)
Adipokines and cytokines in non-alcoholic fatty liver disease
M. H. Jarrar et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Obesity, inflammation, and insulin resistance
Steven E. Shoelson et al.
GASTROENTEROLOGY (2007)
Serum resistin and hepatic fat content in nondiabetic individuals
Gianluca Perseghin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Metabolic and adipokine profile of chinese patients with nonalcoholic fatty liver disease
Vincent Wai-Sun Wong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance
C Pagano et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Adipokines in NASH:: Postprandial lipid metabolism as a link between adiponectin and liver disease
G Musso et al.
HEPATOLOGY (2005)